To ensure that ELRIG fulfils its purpose and remains relevant to the drug discovery community, it is steered by the General Committee, who act as a direct connection to the community and thus is comprised of a diverse group of people.
To join the General Committee, email info@elrig.org.
Download our Articles of Association here: SCHEDULE 2 Regulation 3 (elrig.org)
The current General Committee is:
Emma Howarth
(Langton Howarth)
Simon Chell
(AstraZeneca)
Gerry Alden
(Biosero)
Jeanette Woolard
(Nottingham University)
Matthew Ridley
(University of Liverpool)
Alex Alderton
(AstraZeneca)
Fabrice Turlais
(Evotec )
Louise Affleck
(PKI/Cisbio)
Martin Pearce
(Sygnature)
Saman Honarnejad
(Pivot Park Screening Centre)
Verena Brucklacher-Waldert
(Horizon/PKI)
Emma Shepherd
(Aston University)
Sarah Lupton
(ELRIG)
Michelle Ricketts
(Codon Communications)
Melanie Leveridge
(GSK)
Katie Chapman
(MSD)
Chun-Wa Chung
(GlaxoSmithKline)
Scott Cribbs
(Nexcelom)
Lisa Stott
(Sosei Heptares)
Merve Mutlu
(Novartis Institutes for BioMedical Research)
Theresia Schaedler
(Maxion Therapeutics)
Catherine Kettleborough
(LifeArc)
Malcolm Crook
(Peak Analysis & Automation)
Saleha Patel
(AstraZeneca)
Thomas Edmonds
(Tecan)
Jarrod (Jazz) Walsh
(AstraZeneca)
Emily Norman
(ELRIG)
Willim Lee
(Domainex)
(Domainex)
David Cronk
(Domainex)
Tim Hammonds
(Consultant – Drug Discovery)
Thomas Lundback
(AstraZeneca)
Simon Ward
(Cardiff University)
Steven Trim
(Venomtech)
Bagmi Pattanaik
(Sahlgrenska Academy at University of Gothenburg)
Chris Williams
(Questa)
Clare Cockerham
(ELRIG)
Clare Viney
(CRAC)
Kate Smith
(GSK)
Mark Soave
(Omass Therapeutics)
Paul Kendall
(Watson-Marlow)
Sanj Kumar
(ELRIG)
Rob Howes
(Charles River)
(Charles River)
Jonathan Hutchinson
(GSK)
Nick Clare
(Synthego)
Kevin Moore
(Life Science Professional)
Roger Clark
(Charles River Laboratories)
Sara Schmidt
(AstraZeneca)
Del Trezise
(Sartorius)
Lotta Räty
(Miltenyi)
Martin Main
(Catapult)
Paul Wylie
(Abcam)
Ramila Patel
(Bioeagles)
Kelly Gray
(AstraZeneca)
Tara Shanks
(ELRIG)
David Baker
(AstraZeneca)
James Pilling
(AstraZeneca)